Raghu Ram Achar | Nanotechnology in Medicine and Healthcare | Emerging Nanotech Leader Award

Dr. Raghu Ram Achar | Nanotechnology in Medicine and Healthcare | Emerging Nanotech Leader Award

Dean, Internal Quality Assurance Cell (IQAC) | Mahayogi Gorakhnath University | India 

Dr. Raghu Ram Achar is an accomplished researcher with a strong publication-driven profile in biochemistry, biomedical sciences, and interdisciplinary life science research. His scholarly output comprises 114 research documents indexed in major databases, reflecting consistent contributions through original research articles, high-quality reviews, book chapters, books, and patents. According to Google Scholar, his work has received 1,342 citations, with an h-index of 19 and an i10-index of 36, demonstrating both sustained productivity and significant academic impact. His research spans enzymology, nanobiotechnology, tissue engineering, cancer biology, mitochondrial research, wound healing, bioinformatics, and computational drug discovery, with publications appearing in high-impact, peer-reviewed international journals. He has actively contributed to funded research projects, interdisciplinary R&D initiatives, innovation-driven studies, and translational research outcomes. His profile is further strengthened by research supervision, peer-review services for reputed journals, editorial and conference roles, and recognized scholarly contributions that collectively position him as a credible and impactful contributor to contemporary biomedical and life sciences research.

Citation Metrics (Google Scholar)

2000

1500

1000

500

0

Citations
1342

Documents
114

h-index
19

i10index
36

Citations

Documents

h-index

i10-index

View Scopus Profile  View ORCID Profile  View Google Scholar  View ResearchGate  View Sci Profiles  View Web Of Science  View Loop Profile  View Scilit Profile  View ScholarGPS

Featured Publications

Zhongtao Zhang | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Prof. Dr. Zhongtao Zhang | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Laboratory Director | The Affiliated Taian City Central Hospital of Qingdao University | China

Prof. Dr. Zhongtao Zhang is an accomplished researcher in pharmaceutics and translational pharmaceutical sciences, with a strong focus on advanced drug delivery systems, nano-enabled therapeutics, and precision medicine approaches. His research integrates natural medicinal chemistry, pharmaceutical engineering, and tumor-targeted intervention strategies to address critical challenges in disease treatment and drug bioavailability. He has authored 26 scholarly documents indexed in Scopus, achieving 673 citations and an h-index of 14, reflecting the growing impact and recognition of his work. His publications appear in high-impact international journals such as ACS Nano, Chemical Engineering Journal, Materials Today Bio, and Analytical Chemistry, contributing significantly to nanomedicine, biomaterials, and pharmaceutical innovation. Prof. Dr. Zhongtao Zhang has led multiple competitive research projects supported by national and regional funding agencies and holds several national invention patents, demonstrating strong translational and innovation outcomes. His research contributions continue to advance pharmaceutics, interdisciplinary nanotechnology applications, and clinically oriented pharmaceutical R&D.

Citation Metrics (Scopus)

800

600

400

200

0

Citations
673

Documents
26

h-index
14

Citations

Documents

h-index

View Scopus Profile  View ORCID Profile

Featured Publications

Fang Wang | Nanomaterials for Medicine | Research Excellence Award

Assoc. Prof. Dr. Fang Wang | Nanomaterials for Medicine | Research Excellence Award

China University of Petroleum | China

Assoc. Prof. Dr. Fang Wang is a highly cited researcher with significant contributions to nanotechnology and nanomedicine, reflected by 2,363 Scopus citations across 138 scholarly documents and an h-index of 27. Her research focuses on the design of multifunctional nanoplatforms for precision cancer therapy, integrating DNA nanotechnology, inorganic heterojunctions, and bioresponsive systems. She has made notable advances in targeted drug delivery, photothermal, photodynamic, chemodynamic, and synergistic chemo-therapeutic strategies using programmable nanocomplexes. Her work emphasizes structure–function relationships, catalytic enhancement, and light–matter interactions to achieve high therapeutic efficacy with minimal off-target effects. Assoc. Prof. Dr. Fang Wang’s research outcomes have been published in high-impact international journals, contributing to translational nanomedicine and advanced therapeutic design. She has actively contributed to interdisciplinary R&D, innovation-driven nanomaterial development, peer-review activities, and editorial and conference-related scholarly services, earning recognition for advancing next-generation smart nanotherapeutics.

Citation Metrics (Scopus)

2500

2000

1500

1000

500

0

Citations
2363

Documents
138

h-index
27

Citations

Documents

h-index

View Scopus Profile

Featured Publications


Manganese-doped CeO2 nanoparticles with phosphatase-like activity for dual-mode detection of aluminum ions

Colloids and Surfaces A: Physicochemical and Engineering Aspects, 2025 | Citations: 2

Sofia Mares Bou | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Ms. Sofia Mares Bou | Nanotechnology in Medicine and Healthcare | Research Excellence Award

PhD Student | Centre for Biomaterials and Tissue Engineering (CBIT) – Universitat Politècnica de València (UPV) | Spain

Ms. Sofia Mares Bou is a biomedical engineer with focused research contributions in biomaterials and tissue engineering, emphasizing translational solutions for drug delivery and regenerative medicine. Her scholarly work includes a peer-reviewed journal article in Polymers on core–shell polyvinyl alcohol electrospun microfibers for controlled drug delivery, reflecting expertise in electrospinning, polymeric biomaterials, and therapeutic release systems. She has also presented nationally recognized research on injectable, biomimetic hydrogels for 3D hepatic culture models and hepatotoxicity assessment, contributing to high-throughput in vitro platforms. Ms. Sofia Mares Bou has participated in competitive, publicly funded R&D projects addressing ocular implants for postoperative drug delivery and bioengineered hydrogels with growth-factor presentation. Her research achievements include an award at a national biomedical engineering congress. With Scopus-indexed publications 2, citations 15, and an h-index of 1, her work demonstrates early but impactful contributions to advanced biomaterials, controlled drug delivery, and tissue regeneration research.

Citation Metrics (Scopus)

20

15

10

5

0

Citations
15

Documents
2

h-index
1

Citations

Documents

h-index

View Scopus Profile   View ORCID Profile   View Sci Profiles

Featured Publications

Mustafa Arslan | Nanomedicine | Best Researcher Award

Prof. Dr. Mustafa Arslan | Nanomedicine | Best Researcher Award

Prof. Dr. at Gazi University, Medical Faculty, Turkey.

Prof. Mustafa Arslan is a distinguished medical researcher and professor at Gazi University, specializing in surgery and fundamental medical sciences. With a career spanning over two decades, he has made significant contributions to medical research, particularly in experimental and clinical studies. As the Director of the Experimental and Clinical Research Center at Gazi University, he has played a crucial role in advancing surgical and anesthesia-related research. His extensive academic involvement includes serving on multiple ethics committees, supervising research projects, and mentoring doctoral students. Prof. Arslan has published widely in high-impact medical journals and is recognized for his expertise in ischemia-reperfusion injury models. His active participation in academic and administrative roles highlights his leadership in medical sciences. With a strong presence in international research databases such as Scopus, Web of Science, and Google Scholar, he has established himself as a key figure in medical research. His dedication to medical education, research ethics, and innovative surgical techniques positions him as a leading expert in his field. Prof. Arslan continues to contribute significantly to medical advancements through his research, teaching, and leadership, making him a highly respected figure in the global medical community.

Professional Profile:

Education

Prof. Mustafa Arslan has an extensive educational background in medicine, reflecting his commitment to academic excellence and medical research. He earned his undergraduate degree from Ege University, Faculty of Medicine, in 1994, laying a strong foundation for his future career in surgery and medical sciences. He then pursued an advanced specialization in medicine at Erciyes University, where he focused on fundamental medical sciences from 1999 to 2001. Continuing his academic journey, he obtained further expertise in surgery from Gazi University’s Faculty of Medicine between 2001 and 2006. His dissertation research at Gazi University focused on the comparative effects of desflurane and sevoflurane on rat liver, emphasizing gender and age-related differences. Additionally, his earlier research at Erciyes University explored electrophysiological and electrodermal activity changes in Behçet’s disease, demonstrating his interdisciplinary approach to medicine. Prof. Arslan has also undertaken specialized training in experimental animal research, completing certification in laboratory animal studies at Erciyes University in 2003. His continuous pursuit of knowledge and specialization in surgical and experimental medicine has shaped his career as a researcher and educator, enabling him to contribute significantly to medical sciences through innovative research and clinical advancements.

Professional Experience

Prof. Mustafa Arslan has built an impressive professional career, marked by significant roles in academia, research, and medical administration. Since 2021, he has been serving as a Professor in the Department of Surgical Medical Sciences at Gazi University, where he leads innovative research in experimental medicine and surgery. His administrative contributions include his role as the Director of the Experimental and Clinical Research Center at Gazi University since 2022, where he oversees advanced medical studies and laboratory experiments. He also chairs the Experimental Animals Ethics Committee, ensuring ethical compliance in medical research. Additionally, Prof. Arslan has been an Assistant Manager at the Research and Application Center at Gazi University since 2020, playing a key role in promoting interdisciplinary research collaborations. His long-standing membership on various ethics and academic committees at Gazi University further underscores his influence in shaping research policies and medical education. Over the years, he has supervised numerous doctoral dissertations, conducted specialized courses in anesthesia and systemic diseases, and participated in faculty governance. His vast experience in experimental and clinical medicine, combined with his leadership in medical education, makes him a distinguished figure in academic and medical circles.

Research Interest

Prof. Mustafa Arslan’s research interests span across various domains of medical and surgical sciences, with a particular focus on experimental medicine, anesthesiology, and ischemia-reperfusion injury models. His work in anesthesia research has explored the effects of different anesthetic agents on organ function, particularly in the context of liver and cardiovascular health. He has also conducted in-depth studies on systemic diseases and their impact on surgical outcomes. His research in ischemia-reperfusion injury has led to new insights into the mechanisms of cellular damage and potential therapeutic interventions. Prof. Arslan is also deeply interested in the ethical and methodological aspects of experimental research, leading various committees to ensure high standards in medical investigations. His expertise extends to the use of experimental animal models in medical research, where he has contributed to advancing surgical techniques and improving post-operative care. He remains committed to interdisciplinary research, collaborating with experts in pharmacology, physiology, and biomedical engineering to develop innovative medical solutions. Through his research, he aims to improve surgical outcomes, enhance patient safety, and contribute to the development of novel medical treatments and technologies.

Research Skills

Prof. Mustafa Arslan possesses a diverse set of research skills that make him a leader in medical and surgical sciences. His expertise in experimental research methodologies allows him to design and execute complex studies involving animal models and clinical trials. He is proficient in advanced surgical techniques, particularly in the study of ischemia-reperfusion injuries and anesthesia-related complications. His skills in electrophysiological assessments and biomedical instrumentation enable him to conduct high-precision studies on systemic diseases and their effects on the human body. Prof. Arslan is also well-versed in statistical analysis and research data interpretation, ensuring the accuracy and reliability of his findings. His experience in research ethics and laboratory management has equipped him with the ability to oversee large-scale experimental projects while maintaining compliance with ethical guidelines. Additionally, he has strong mentorship and academic writing skills, having supervised multiple doctoral theses and published extensively in peer-reviewed journals. His ability to integrate medical research with technological advancements makes him a valuable contributor to modern medical science.

Awards and Honors

Throughout his career, Prof. Mustafa Arslan has received numerous accolades in recognition of his contributions to medical research and education. His outstanding research achievements have earned him multiple institutional awards at Gazi University, where he has been recognized for his excellence in experimental and clinical medicine. His role in ethical research and academic governance has also been acknowledged through his appointments to key committee positions, demonstrating the trust placed in him by his peers. Additionally, his active participation in academic conferences, jury memberships, and doctoral supervision has been instrumental in shaping medical education and research in Turkey. Prof. Arslan’s contributions to anesthesia and ischemia-reperfusion injury research have gained significant recognition, positioning him as an influential figure in his field. His commitment to ethical research practices and continuous academic development further underscores his reputation as a dedicated researcher and educator. While his achievements are already substantial, his ongoing research and contributions to medical sciences suggest that more prestigious honors await him in the future.

Conclusion

Prof. Mustafa Arslan is a highly accomplished researcher, educator, and medical professional whose contributions to surgical and experimental medicine have had a profound impact. His expertise in anesthesia, ischemia-reperfusion injury models, and systemic disease research, combined with his leadership in medical ethics and experimental research, positions him as a leading figure in medical sciences. His extensive academic and administrative experience at Gazi University, along with his mentorship of future medical researchers, highlights his dedication to advancing medical knowledge and improving patient outcomes. His strong research skills, ethical leadership, and commitment to interdisciplinary collaboration make him a deserving candidate for prestigious research awards. While he has already earned significant recognition, expanding his international collaborations and securing more research grants could further enhance his global impact. Overall, Prof. Arslan’s remarkable career and contributions to medical research solidify his reputation as an outstanding scientist and educator in the field of medicine.

Publication Top Notes

  • Effects of Pomegranate Seed Oil on Lower Extremity Ischemia-Reperfusion Damage: Insights into Oxidative Stress, Inflammation, and Cell Death
    📌 Medicina, 2025-01-24 | DOI: 10.3390/medicina61020212
    Contributors: Ümmü Gülşen Bozok, Aydan İremnur Ergörün, Ayşegül Küçük, Zeynep Yığman, Ali Doğan Dursun, Mustafa Arslan
  • Effects of Cerium Oxide on Kidney and Liver Tissue Damage in an Experimental Myocardial Ischemia-Reperfusion Model of Distant Organ Damage
    📌 Medicina, 2024-12-11 | DOI: 10.3390/medicina60122044
    Contributors: Işın Güneş, Ali Doğan Dursun, Çağrı Özdemir, Ayşegül Küçük, Şaban Cem Sezen, Mustafa Arslan, Abdullah Özer
  • The Effect of Silymarin on Ischemia-Reperfusion Injury in Skeletal Muscles of Rats
    📌 Turkish Journal of Vascular Surgery, 2024-11-15 | DOI: 10.9739/tjvs.2024.09.038
    Contributors: Abdullah Ozer, Basak Kocak, Mustafa Arslan, Baris Mardin, Aysegul Kucuk, Saban Cem Sezen, Mustafa Hakan Zor, Mustafa Kavutcu
  • Ozone Administration Reduces Myocardial Ischemia Reperfusion Injury in Streptozotocin Induced Diabetes Mellitus Rat Model
    📌 Drug Design, Development and Therapy, 2024-09 | DOI: 10.2147/DDDT.S482309
    Contributors: Mehmet Gülcan, Hüseyin Demirtaş, Abdullah Özer, Zeynep Yığman, Ali Dursun, Mustafa Arslan, Gürsel Oktar
  • Evaluation of the Efficacy of Ozone Therapy on Liver Tissue in the Treatment of Sepsis in Rats with Cecal Perforation
    📌 Medicina, 2024-09-22 | DOI: 10.3390/medicina60091552
    Contributors: Selin Erel, Ayşegül Küçükk, Kürşat Dikmen, Esin Tekin, Zeynep Yığman, Müşerref Şeyma Ceyhan, Seda Gökgöz, Hasan Bostancı, Mustafa Arslan, Mustafa Kavutcu

Ms. Moloud Farrokhi | Nanodelivery Awards | Best Researcher Award

Ms. Moloud Farrokhi | Nanodelivery Awards | Best Researcher Award

Ms. Moloud Farrokhi , Albany Medical college, United States

Mouloud Farrokhi is an experienced immunologist and microbiologist specializing in HIV/AIDS research, nanoparticle delivery systems, and viral infections. He is currently pursuing a PhD in Biology with a focus on Immunology and Microbiology at Albany Medical College, USA. Mouloud has a strong academic and professional background, having worked as a research assistant and medical laboratory scientist in Iran and Sweden. His research aims to improve understanding and treatment of viral infections, with significant contributions to HIV drug resistance and oncolytic virus therapy. Mouloud’s work also extends to the development of innovative nanoparticle-based drug delivery systems, offering promising solutions for invasive infections like Aspergillosis. His expertise spans from molecular biology to clinical research, with an emphasis on laboratory techniques like PCR, qRT-PCR, NGS, and CRISPR/Cas9.

Professional Profile:

Google Scholar

Mouloud Farrokhi: A Strong Contender for the Research Best Researcher Award

Mouloud Farrokhi is an exceptional candidate for the Research Best Researcher Award due to his extensive background in immunology, microbiology, and viral infections, as well as his significant contributions to molecular diagnostics and therapeutic innovations. His educational qualifications, research experience, and recognition in the field of medical sciences make him a highly suitable candidate for this prestigious award.

🎓Education:

Mouloud Farrokhi is currently pursuing a PhD in Biology, specializing in Immunology and Microbiology at Albany Medical College, USA (2023–Present). He holds two Master’s degrees: an MSc in Bioscience from the University of Skövde, Sweden (2021–2022), with a thesis on the role of RABL6 in AP3-dependent trafficking, and an MSc in Cellular and Molecular Biology from the Islamic Azad University, Iran (2010–2014), where he researched HIV-1 drug resistance. His undergraduate studies were in Marine Biology at the Islamic Azad University, Tehran, Iran (2003–2008). Mouloud’s extensive education in biological sciences provides a solid foundation for his current research endeavors, focusing on viral infections, molecular diagnostics, and therapeutic innovations.

🏢Experience:

Mouloud Farrokhi has gained extensive experience as a research assistant and medical laboratory scientist. He worked as a Research Assistant at Tehran University of Medical Sciences (2022–2023), where he focused on statistical analysis and NGS (Next Generation Sequencing). He has also served as a Medical Laboratory Assistant at Tehran University of Medical Sciences (2018–2021), where he conducted HIV viral load analysis and COVID-19 testing via qPCR. His previous roles include being a Medical Laboratory Scientist at Dena Lab (2017–2018), where he performed NITP tests and a Research Assistant at Pasteur Institute of Iran (2016–2017), where he researched drug resistance in HIV and HCV. He has also contributed to laboratory work at Keyvan Virology Laboratory, Tehran (2015–2016). Mouloud’s diverse hands-on experience makes him proficient in molecular biology techniques, data analysis, and lab management.

🏅Awards and Honors:

Mouloud Farrokhi’s academic and research achievements are reflected in his high academic standing and contributions to scientific research. His thesis at the University of Skövde received top marks, with a GPA of 3.75, and he has consistently demonstrated excellence throughout his academic career. His research contributions have been recognized in various publications and presentations. Notably, he presented at the International Student Congress in Medical Sciences (ISCOM) in 2017 and at the Upstate New York Immunology Conference (NYIC) in 2024. Mouloud’s work in HIV drug resistance and nanoparticle drug delivery systems has been published in high-impact journals. His dedication to advancing medical science has led to multiple research opportunities, including participation in workshops on gene transfer and vaccine design.

🔬Research Focus:

Mouloud Farrokhi’s research focuses on immunology, microbiology, and the molecular mechanisms underlying viral infections and drug resistance. He investigates the molecular pathways of HIV and other viral infections, focusing on drug resistance mechanisms in HIV-1 and HCV. His research also explores innovative strategies for oncolytic virus therapy and nanoparticle-based drug delivery, with the goal of improving treatment outcomes for invasive infections like Aspergillosis. Additionally, he is involved in genetic analysis and genomic editing technologies such as CRISPR/Cas9. Mouloud’s work integrates molecular diagnostics and therapeutic advancements, contributing significantly to both basic science and clinical applications in virology and immunology.

Publication Top Notes:

  • “Subtype classification of Iranian HIV-1 sequences registered in the HIV databases, 2006-2013”
    • Citations: 31
  • “HIV drug resistance among naïve HIV-infected patients in Iran”
    • Citations: 14
  • “Antiretroviral drug resistance mutations among HIV treatment failure patients in Tehran, Iran”
    • Citations: 11
  • “The first characterization of HIV-1 subtypes and drug resistance mutations among antiretrovirally treated patients in Kermanshah, Iran”
    • Citations: 9
  • “HIV drug resistance and phylogeny profile in naive and antiretroviral-experienced patients in Tehran, Iran”
    • Citations: 8